For: | Jiang Y, Chowdhury S, Xu BH, Meybodi MA, Damiris K, Devalaraju S, Pyrsopoulos N. Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection. World J Hepatol 2021; 13(11): 1777-1790 [PMID: 34904045 DOI: 10.4254/wjh.v13.i11.1777] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i11/1777.htm |
Number | Citing Articles |
1 |
Yana V Kiseleva, Roman V Maslennikov, Aida N Gadzhiakhmedova, Tatyana S Zharikova, Dmitry V Kalinin, Yury O Zharikov. <i>Clostridioides difficile</i> infection in patients with nonalcoholic fatty liver disease-current status. World Journal of Hepatology 2023; 15(2): 208-215 doi: 10.4254/wjh.v15.i2.208
|
2 |
Ankoor H. Patel, Gaurav N. Pathak, Alexander Chen, Patricia Greenberg, Natale Mazzaferro, Anish Patel, Naveen Mallangada, Carlos D. Minacapelli, Kaitlyn Catalano, Hansel Suthar, Vinod K. Rustgi. Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH. Annals of Hepatology 2024; 29(4): 101510 doi: 10.1016/j.aohep.2024.101510
|
3 |
Estefanía Caballano-Infantes, Ailec Ho-Plágaro, Carlos López-Gómez, Flores Martín-Reyes, Francisca Rodríguez-Pacheco, Bernard Taminiau, Georges Daube, Lourdes Garrido-Sánchez, Guillermo Alcaín-Martínez, Raúl J. Andrade, Miren García-Cortés, M. Isabel Lucena, Eduardo García-Fuentes, Cristina Rodríguez-Díaz. Membrane Vesicles of Toxigenic Clostridioides difficile Affect the Metabolism of Liver HepG2 Cells. Antioxidants 2023; 12(4): 818 doi: 10.3390/antiox12040818
|